The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Vifor Fresenius Medical Care Renal Pharma FranceEU/1/14/943/005

Main Information

Trade NameVelphoro
Active SubstancesSucroferric Oxyhydroxide
Dosage FormOral powder in sachet
Licence HolderVifor Fresenius Medical Care Renal Pharma France
Licence NumberEU/1/14/943/005

Group Information

ATC CodeV03AE05 sucroferric oxyhydroxide


License statusAuthorised
Licence Issued16/11/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back